Universal Biosensors, Inc.

ASX:UBI Stock Report

Market Cap: AU$4.2m

Universal Biosensors Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure6.6yrs

Recent management updates

Recent updates

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

Dec 11
We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

Nov 09
We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

May 03
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

Jan 12
We Think Universal Biosensors (ASX:UBI) Needs To Drive Business Growth Carefully

We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Oct 10
We're Keeping An Eye On Universal Biosensors' (ASX:UBI) Cash Burn Rate

Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In Growth

Apr 28
Companies Like Universal Biosensors (ASX:UBI) Are In A Position To Invest In Growth

We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

May 13
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?

Feb 24
Should You Take Comfort From Insider Transactions At Universal Biosensors, Inc. (ASX:UBI)?

We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

Jan 20
We Think Universal Biosensors (ASX:UBI) Can Afford To Drive Business Growth

The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For More

Dec 15
The Universal Biosensors (ASX:UBI) Share Price Has Gained 95% And Shareholders Are Hoping For More

CEO

Universal Biosensors has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Salesh Balak
Company Secretary & Corporate Advisor6.8yrsAU$250.70k0%
A$ 0
Peter Mullin
MD, Finance Directorless than a yearno data0.85%
A$ 35.6k
Luke Cossins
C.T.Oless than a yearno datano data
Keith Sims
Global Marketing Director1.8yrsno datano data
Ann Chew
Head of People Strategy & Culture3.8yrsno datano data
1.8yrs
Average Tenure

Experienced Management: UBI's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Peter Mullin
MD, Finance Directorless than a yearno data0.85%
A$ 35.6k
David Hoey
Independent Non-Executive Director9.6yrsAU$77.60k0.22%
A$ 9.3k
Judith Smith
Independent Non-Executive Director10.6yrsAU$86.33k0.15%
A$ 6.2k
Graham McLean
Independent Non-Executive Chairman3.6yrsAU$114.14k0.36%
A$ 15.1k
David Church
Member of the Scientific Advisory Panelno datano datano data
John Loftus
Member of the Scientific Advisory Panelno datano datano data
Simon Corrie
Member of the Scientific Advisory Panelno datano datano data
Steve Kitchen
Member of the Scientific Advisory Panelno datano datano data
Sam Schulman
Member of the Scientific Advisory Panelno datano datano data
Davide Matino
Member of the Scientific Advisory Panelno datano datano data
Eric Wilkes
Member of the Scientific Advisory Panelno datano datano data
Nicolas Voelcker
Member of the Scientific Advisory Panelno datano datano data
6.6yrs
Average Tenure
62.5yo
Average Age

Experienced Board: UBI's board of directors are considered experienced (6.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/24 22:36
End of Day Share Price 2025/08/19 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Universal Biosensors, Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tara SperanzaBell Potter
Shane StoreyCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.